Human Respiratory Syncytial Virus Subgroup A and B Infections in Nasal, Bronchial, Small-Airway, and Organoid-Derived Respiratory Cultures
- L. C. Rijsbergen
- M. M. Lamers
- A. D. Comvalius
- R. W. Koutstaal
- D. Schipper
- W. P. Duprex
- B. L. Haagmans
- R. D. de Vries
- R. L. de Swart
Publication date
June 2021
DOI Publisher
American Society for Microbiology Journal
mSphereAbstract
Human respiratory syncytial virus (HRSV) is the major cause of bronchiolitis and pneumonia in young infants and causes almost 200,000 deaths per year. Currently, there is no vaccine or treatment available, only a prophylactic monoclonal antibody (palivizumab)
Add to ORKG